Kirk Ways
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Ophthalmology top 2%
- Retinal Diseases and Treatments
Papers in
-
- Diabetes Treatment and Management 10
- Diabetes Management and Research 5
-
- Metabolism, Diabetes, and Cancer 5
- Retinoids in leukemia and cellular processes 2
- Ubiquitin and proteasome pathways 2
- Co-authors
- Gary Meininger (3 shared papers)Mehul Desai (3 shared papers)Keith Usiskin (3 shared papers)Ngozi Erondu (1 shared paper)Julio Rosenstock (2 shared papers)Paul Nyirjesy (2 shared papers)George Capuano (3 shared papers)Hidehiro Ishii (1 shared paper)
- Journals
- Current Medical Research and Opinion (3 papers)Diabetes Care (3 papers)Endocrinology (1 paper)Oncology Reports (1 paper)Diabetes (1 paper)
- Partner nations
- United StatesBelgiumAustralia
In The Last Decade
Kirk Ways
20 papers receiving 2.0k citations
Kirk Ways's Hit Papers
Peers
Comparison fields: 5 of 93
- Endocrinology, Diabetes and Metabolism 1.3k
- Ophthalmology 347
- Surgery 805
- Clinical Biochemistry 97
- Pharmacology 208
Countries citing papers authored by Kirk Ways
This map shows the geographic impact of Kirk Ways's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk Ways with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk Ways more than expected).
Fields of papers citing papers by Kirk Ways
This network shows the impact of papers produced by Kirk Ways. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk Ways. The network helps show where Kirk Ways may publish in the future.
Co-authors
The 25 scholars most cited alongside Kirk Ways, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor Hit paper breakdown → | 1997 | 515 |
| 2 | 2015 | 238 | |
| 3 | 2012 | 200 | |
| 4 | 2012 | 192 | |
| 5 | 2014 | 183 | |
| 6 | 2014 | 127 | |
| 7 | 2012 | 119 | |
| 8 | 2004 | 113 | |
| 9 | 2005 | 85 | |
| 10 | 2015 | 79 | |
| 11 | 2012 | 67 | |
| 12 | 1992 | 65 | |
| 13 | 1992 | 34 | |
| 14 | 1991 | 31 | |
| 15 | 2014 | 17 | |
| 16 | 2014 | 10 | |
| 17 | 1993 | 8 | |
| 18 | 1987 | 7 | |
| 19 | 1998 | 6 | |
| 20 | 1996 | 2 |
About Kirk Ways
Kirk Ways is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery, Pharmacology and Ophthalmology, having authored 20 papers that have together received 2.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (10 papers), Pancreatic function and diabetes (8 papers), Diabetes Management and Research (5 papers), Metabolism, Diabetes, and Cancer (5 papers), Glaucoma and retinal disorders (2 papers), Retinoids in leukemia and cellular processes (2 papers), Retinal Diseases and Treatments (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.3k citations), Ophthalmology (347 citations), Surgery (805 citations), Clinical Biochemistry (97 citations) and Pharmacology (208 citations). Kirk Ways has collaborated with scholars based in United States, Belgium and Australia. Frequent co-authors include Gary Meininger, Mehul Desai, Keith Usiskin, Ngozi Erondu, Julio Rosenstock, Paul Nyirjesy, George Capuano, Hidehiro Ishii, Michael R. Jirousek and Thomas A. Ciulla. Their work appears in journals such as Current Medical Research and Opinion, Diabetes Care, Endocrinology, Oncology Reports and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.